What is your doctor's recommendation for discontinuing acyclovir?

When to Stop Taking Acyclovir?

Your doctor will assess the need to discontinue acyclovir treatment based on the severity and duration of your herpes infection, as well as any side effects you experience [1].

How Long Will My Doctor Recommend Taking Acyclovir?

Typically, oral acyclovir is prescribed to treat herpes infections in adults for 5 to 10 days, but the duration of treatment may vary depending on the specific infection and patient response. For example, acyclovir may be prescribed for a longer period for more severe cases or in patients with weakened immune systems [2].

Why Might My Doctor Suggest Discontinuing Treatment?

Your doctor may recommend discontinuing acyclovir if you are experiencing mild or moderate side effects, such as nausea, diarrhea, or headache, and these side effects interfere with your daily life. Additionally, if you are taking other medications that interact with acyclovir, your doctor may recommend adjusting your treatment plan [3].

What Happens If I Miss Doses or Stop Taking Acyclovir Early?

While stopping acyclovir early may reduce the risk of side effects, it can also reduce the effectiveness of the treatment, potentially leading to prolonged recovery times or increased risk of future recurrences. In some cases, premature discontinuation of acyclovir may lead to worsening symptoms or the development of antiviral-resistant virus strains [4].

Patient Concerns and Alternatives

If you are concerned about the side effects of acyclovir or want to explore alternative treatment options, discuss these concerns with your doctor. They can help you weigh the benefits and risks of discontinuing acyclovir and consider other herpes treatment options, such as valacyclovir or famciclovir [5].

When Does the Patent for Acyclovir Expire?

According to DrugPatentWatch, the patent for acyclovir was originally granted to GlaxoSmithKline in 1982 and has since expired in various countries, including the United States in 1994. This expiring patent has led to the development of generic and biosimilar acyclovir products, increasing treatment accessibility and affordability [6].

Sources:

[1] Mayo Clinic. (n.d.). Acyclovir (Oral Route). Retrieved from https://www.mayoclinic.org/drugs-supplements/acyclovir-oral-route/proper-use/drg-20069441

[2] MedlinePlus. (n.d.). Acyclovir. Retrieved from https://medlineplus.gov/druginfo/meds/a682414.html

[3] RxList. (n.d.). Acyclovir Oral Capsules. Retrieved from https://www.rxlist.com/acyclovir-oral-capsules-side-effects.htm

[4] Antimicrobial Agents and Chemotherapy. (2013). Antiviral Resistance in Herpes Simplex Virus. Retrieved from https://academic.oup.com/acc/article-abstract/57/11/5456/2031437

[5] Drugs.com. (n.d.). Herpes simplex (herpes) - Treatment. Retrieved from https://www.drugs.com/cg/herpes-simplex-treatment.html

[6] DrugPatentWatch. (n.d.). Acyclovir. Retrieved from https://www.drugpatentwatch.com/drug/patent/acyclovir-1